Title:
【発明の名称】ペプチドT投与による前期遺伝子発現変更に基づくウィルス性疾患その他の疾病治療法
Document Type and Number:
Japanese Patent JP2003528817
Kind Code:
A
Abstract:
A method for inhibiting viral replication and for treating neurotropic conditions by regulating/inhibiting immediate early gene expression in host cells comprises administrating an inhibiting/regulating effective amount of a peptide of formula (I): R-Ser-Thr-Thr-Thr-Asn-Tyr-R where R represents an amino terminal residue Ala- or D- Ala and R represents a carboxy terminal residue -Thr or -Thr amide or a derivative thereof with an additional Cys- residue at one or both of the amino and carboxy terminals, or a peptide of formula (II): R1-R2-R3-R4-R5 where R1 is an amino terminal residue Thr-, Ser-, Asn-, Glu-, Arg-, Ile- or Leu-, R2 is Thr, Ser, or Asp, R3 is Thr, Ser, Asn, Arg, Gln, Lys, or Trp, R4 is Tyr and R5 is preferably a carboxy terminal residue -Thr, -Arg or Gly or a derivative thereof with a corresponding D-amino acid as the amino terminal residue, and/or a corresponding amide derivative at the carboxy terminal residue and/or additionally a Cys- residue at one or both of the amino and carboxy terminals, in a physiologically suitable carrier.
Inventors:
Addams melibeth
Fairland Dean
Hoof sydney
Fairland Dean
Hoof sydney
Application Number:
JP2001536100A
Publication Date:
September 30, 2003
Filing Date:
November 09, 2000
Export Citation:
Assignee:
Advanced Immunity Incorporated
International Classes:
A61K38/00; A61K38/08; A61P25/00; A61P25/28; A61P31/12; A61P37/02; A61P37/06; C07K7/06; (IPC1-7): A61K38/00; A61P25/00; A61P25/28; A61P31/12; A61P37/02; A61P37/06
Attorney, Agent or Firm:
Yoshimura Katsutoshi